DENTSPLY SIRONA (NASDAQ:XRAY) Rating Lowered to "Hold" at Jefferies Financial Group

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) was downgraded by analysts at Jefferies Financial Group from a "buy" rating to a "hold" rating in a report issued on Thursday, MarketBeat Ratings reports. They currently have a $20.00 price objective on the medical instruments supplier's stock, down from their prior price objective of $30.00. Jefferies Financial Group's target price points to a potential upside of 2.83% from the company's previous close.

XRAY has been the topic of a number of other reports. Leerink Partners downgraded shares of DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a report on Thursday, November 7th. Leerink Partnrs cut shares of DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a research note on Thursday, November 7th. UBS Group reduced their price target on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating for the company in a research report on Tuesday, December 3rd. Robert W. Baird lowered their price objective on DENTSPLY SIRONA from $31.00 to $24.00 and set a "neutral" rating on the stock in a research report on Friday, November 8th. Finally, Morgan Stanley reduced their target price on DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating for the company in a research report on Tuesday, December 17th. Ten investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $26.67.

DENTSPLY SIRONA Stock Performance

XRAY traded up $0.09 on Thursday, hitting $19.45. The company's stock had a trading volume of 1,857,713 shares, compared to its average volume of 2,467,687. DENTSPLY SIRONA has a 12 month low of $17.21 and a 12 month high of $35.68. The firm has a market cap of $3.87 billion, a P/E ratio of -9.37, a price-to-earnings-growth ratio of 1.77 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The company's 50 day simple moving average is $18.98 and its 200-day simple moving average is $22.74.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping analysts' consensus estimates of $0.48 by $0.02. The firm had revenue of $951.00 million during the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The business's revenue for the quarter was up .4% on a year-over-year basis. During the same period last year, the company earned $0.49 earnings per share. Analysts forecast that DENTSPLY SIRONA will post 1.84 EPS for the current year.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of large investors have recently modified their holdings of XRAY. UMB Bank n.a. lifted its holdings in DENTSPLY SIRONA by 430.3% in the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier's stock worth $25,000 after buying an additional 753 shares during the period. Capital Performance Advisors LLP purchased a new position in shares of DENTSPLY SIRONA in the 3rd quarter valued at approximately $27,000. MassMutual Private Wealth & Trust FSB boosted its position in shares of DENTSPLY SIRONA by 648.4% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock valued at $27,000 after purchasing an additional 1,232 shares in the last quarter. Kennebec Savings Bank bought a new stake in shares of DENTSPLY SIRONA during the third quarter valued at approximately $35,000. Finally, Van ECK Associates Corp bought a new position in DENTSPLY SIRONA in the third quarter worth $42,000. Institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.